Prof. Yunyan Zhang 张云艳
Chief Physician, Professor
Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and comprehensive treatment of cervical, endometrial, ovarian, vulvar, and vaginal cancers. Specializes in radiotherapy for advanced and recurrent cervical cancer, using techniques such as 3D brachytherapy and image-guided radiotherapy (IGRT-VMAT).
Dr. Zhang is Chief Physician and Professor at Harbin Medical University Cancer Hospital, leading the Gynecologic Radiotherapy Ward. Dr. Zhang earned a master’s in Obstetrics and Gynecology (2001) and a PhD in Medical Genetics (2004) from Harbin Medical University. Dr. Zhang completed training at the Cancer Hospital of the Chinese Academy of Medical Sciences (2005) and the University of Pittsburgh Medical Center (2008).
Professional roles
- Vice Chair, Gynecologic Oncology Youth Professional Committee, Heilongjiang Anti-Cancer Association
- Member, Sarcoma Professional Committee, Heilongjiang Anti-Cancer Association
- Member, Radiation Oncology Professional Committee, Heilongjiang Anti-Cancer Association
- Member, Biological Therapy Professional Committee, Heilongjiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Yunyan). Papers usually list the name as Yunyan Zhang or Zhang Y.
Selected publications
39 papers on PubMed matched by name and affiliation; 20 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biomater Sci, 2026 (senior author): Responsive accumulation of ultrasmall DNA@WO(3-x) nanodots for suppressing tumor progression and metastasis via single-nanodot triple-therapeutic effects. PubMed 42872479
- ACS Appl Bio Mater, 2026 (senior author): Hydrogen Peroxide Responsive Hafnium-Based Nanomaterials for Enhanced Tumor Radiosensitization. PubMed 42267596
- Front Biosci (Landmark Ed), 2026 (senior author): Pan-Cancer Analysis Identifies GNPNAT1 as a Potential Prognostic Biomarker and Immune-Related Factor. PubMed 42216542
- Front Biosci (Landmark Ed), 2025 (senior author): Excavation of Molecular Subtypes of Cervical Cancer Based on DNA Methylation Patterns. PubMed 41074436
- BMC Cancer, 2025 (senior author): Radiomics feature is a risk factor for locally advanced cervical cancer treated using concurrent chemoradiotherapy based on magnetic resonance imaging: a retrospective study. PubMed 39930343
- Drug Dev Res, 2024 (senior author): RecQ protein-like 4 drives cisplatin chemosensitivity of cervical cancer cells by modulating annexin A2. PubMed 39404003
- Adv Sci (Weinh), 2024 (senior author): Computed Tomography Imaging Guided Microenvironment-Responsive Ir@WO(3-x) Dual-Catalytic Nanoreactor for Selective Radiosensitization. PubMed 39102342
- Int J Nanomedicine, 2024 (senior author): Tumor Cell-Targeting and Tumor Microenvironment-Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic/Photothermal/Chemodynamic Treatment of Cervical Cancer. PubMed 38887692
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion